Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Kidney Transplantation

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 124 articles:
HTML format



Single Articles


    March 2024
  1. PALMER ND, Freedman BI
    APOL1-mediated and Mendelian forms of "heretofore" idiopathic collapsing glomerulopathy: lessons from Brazil.
    Kidney Int. 2024;105:437-439.
    PubMed     Abstract available


  2. RAINA R, Jothi S, Haffner D, Somers M, et al
    Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements.
    Kidney Int. 2024;105:450-463.
    PubMed     Abstract available


  3. SHIRAI Y, Miura K, Ishizuka K, Ando T, et al
    A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence.
    Kidney Int. 2024;105:608-617.
    PubMed     Abstract available


  4. GILL JS, Chadban SJ
    Pretransplant screening for coronary artery disease: data are required before practice change.
    Kidney Int. 2024;105:470-472.
    PubMed     Abstract available


    February 2024
  5. VENKATARAMAN K, McTaggart SJ, Collins MG
    Choosing fluids to reduce the risks of acute electrolyte disturbances in children after a kidney transplant.
    Kidney Int. 2024;105:247-250.
    PubMed     Abstract available


  6. HAAS M
    Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence.
    Kidney Int. 2024;105:240-242.
    PubMed     Abstract available


  7. SHAH Y, Yang H, Mueller FB, Li C, et al
    Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
    Kidney Int. 2024;105:347-363.
    PubMed     Abstract available


  8. LOBAN K, Fadel E, Nugus P, Przybylak-Brouillard A, et al
    Living kidney donors' health care needs, experiences, and perspectives across their entire donation trajectory: a semistructured, in-depth interview study.
    Kidney Int. 2024;105:251-258.
    PubMed    


  9. YI Z, Xi C, Menon MC, Cravedi P, et al
    A large-scale retrospective study enabled deep-learning based pathological assessment of frozen procurement kidney biopsies to predict graft loss and guide organ utilization.
    Kidney Int. 2024;105:281-292.
    PubMed     Abstract available


    January 2024
  10. LUO X, Knechtle S
    The T-cell environment: may the regulatory force be with you.
    Kidney Int. 2024;105:20-22.
    PubMed     Abstract available


    October 2023
  11. HAYES WN, Laing E, Brown R, Silsby L, et al
    A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO).
    Kidney Int. 2023 Oct 30:S0085-2538(23)00760-3. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available


  12. BUDDE K, Rostaing L
    A first small step toward personalized immunosuppression.
    Kidney Int. 2023;104:652-654.
    PubMed     Abstract available


  13. BAILLY E, Macedo C, Ossart J, Louis K, et al
    Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56(dim)CD16(bright) natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.
    Kidney Int. 2023;104:707-723.
    PubMed     Abstract available


    September 2023
  14. VON SAMSON-HIMMELSTJERNA FA, Kolbrink B, Schulte K
    Relative excess mortality risk after kidney transplantation: Eve's loss or Adam's win?
    Kidney Int. 2023;104:619-620.
    PubMed    


  15. SARWAL MM, Naesens M
    Urine trumps the protocol biopsy for subclinical rejection surveillance.
    Kidney Int. 2023;104:432-439.
    PubMed    


  16. NAKAMURA Y, Inoue T
    Tolerogenic dendritic cells: promising cell therapy for acute kidney injury.
    Kidney Int. 2023;104:420-422.
    PubMed     Abstract available


    August 2023
  17. STEHLE T, Letavernier E, Joher N, Mesnard L, et al
    Tolvaptan to prevent calcium oxalate crystal deposition in the kidney allograft after kidney transplantation for primary hyperoxaluria.
    Kidney Int. 2023;104:398.
    PubMed    


  18. EMMONS BR, Batal I, Radhakrishnan J, Husain SA, et al
    Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort.
    Kidney Int. 2023;104:394-397.
    PubMed    


    July 2023
  19. METRY EL, Deesker LJ, Garrelfs SF, Oosterveld MJS, et al
    Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy.
    Kidney Int. 2023;104:203-204.
    PubMed    


  20. TANTISATTAMO E, Kalantar-Zadeh K
    PRECEDE/PROCEED framework for public health program planning in preparation for current and future unprecedented events for patients with kidney failure and living with a kidney transplant.
    Kidney Int. 2023;104:202-203.
    PubMed    


    June 2023
  21. LLOBERAS N, Grinyo JM, Colom H, Vidal-Alabro A, et al
    A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
    Kidney Int. 2023 Jun 28:S0085-2538(23)00475-1. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available


  22. DE FIJTER JW, Dreyer GJ, Mallat MJ, Budde K, et al
    A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.
    Kidney Int. 2023 Jun 19:S0085-2538(23)00419-2. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available


  23. ISNARD P, Tang E, Mroue A, Letavernier E, et al
    The Case | Crescentic glomerulonephritis in a kidney transplant recipient.
    Kidney Int. 2023;103:1205-1206.
    PubMed    


  24. JEHN U, Kohler M, Reuter S
    An unusual case of ascites after kidney transplantation.
    Kidney Int. 2023;103:1203.
    PubMed    


  25. TRUCHOT A, Raynaud M, Loupy A
    Excess mortality after kidney transplantation: does sex matter?
    Kidney Int. 2023;103:1023-1024.
    PubMed     Abstract available


  26. MCDANIELS JM, Shetty AC, Kuscu C, Kuscu C, et al
    Single nuclei transcriptomics delineates complex immune and kidney cell interactions contributing to kidney allograft fibrosis.
    Kidney Int. 2023;103:1077-1092.
    PubMed     Abstract available


    May 2023
  27. BEADLE J, Papadaki A, Toulza F, Santos E, et al
    Application of the Banff Human Organ Transplant Panel to kidney transplant biopsies with features suspicious for antibody-mediated rejection.
    Kidney Int. 2023 May 10:S0085-2538(23)00331-9. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available


  28. GANDOLFINI I, Alibrandi S, Gentile M, Russo LS, et al
    Targeted-release budesonide in recurrent IgA nephropathy after kidney transplantation.
    Kidney Int. 2023;103:995-996.
    PubMed    


  29. SCHOLD JD
    The promise and reality of machine-learning models in kidney transplantation.
    Kidney Int. 2023;103:835-836.
    PubMed     Abstract available


  30. TRUCHOT A, Raynaud M, Kamar N, Naesens M, et al
    Machine learning does not outperform traditional statistical modelling for kidney allograft failure prediction.
    Kidney Int. 2023;103:936-948.
    PubMed     Abstract available


    April 2023
  31. BANJONGJIT A, Wuttiputhanun T, Vanichanan J, Ueaphongsukkit T, et al
    The Case | Hematuria and hypercalcemia in a kidney transplant recipient.
    Kidney Int. 2023;103:801-802.
    PubMed    


  32. RHEE EP
    Kidney-specific metabolomic profiling in machine perfusate.
    Kidney Int. 2023;103:661-663.
    PubMed     Abstract available


  33. BASU S, Dorling A, Chong AS
    A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection.
    Kidney Int. 2023;103:658-660.
    PubMed     Abstract available


  34. LIU RX, Koyawala N, Thiessen-Philbrook HR, Doshi MD, et al
    Untargeted metabolomics of perfusate and their association with hypothermic machine perfusion and allograft failure.
    Kidney Int. 2023;103:762-771.
    PubMed     Abstract available


    March 2023
  35. DANGER R, Le Berre L, Cadoux M, Kerleau C, et al
    Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression.
    Kidney Int. 2023 Mar 27:S0085-2538(23)00186-2. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available


    February 2023
  36. VINSON A, Zhang X, Dahhou M, Susal C, et al
    A multinational cohort study uncovered sex differences in excess mortality after kidney transplant.
    Kidney Int. 2023 Feb 17:S0085-2538(23)00083-2. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available


  37. JOHNSON RJ, Warady BA
    Does kidney transplant improve health-related quality of life for youth with chronic kidney disease?
    Kidney Int. 2023;103:256-258.
    PubMed     Abstract available


    January 2023
  38. SAPIR-PICHHADZE R, Oertelt-Prigione S
    P3(2): A Sex- and Gender-Sensitive Model for Evidence-Based Precision Medicine - from Knowledge Generation to Implementation in the Field of Kidney Transplantation.
    Kidney Int. 2023 Jan 30:S0085-2538(23)00053-4. doi: 10.1016/j.kint.2022.
    PubMed     Abstract available


    November 2022
  39. CHERUKURI A, Abou-Daya KI, Chowdhury R, Mehta RB, et al
    Transitional B cell Cytokines Risk Stratify Early Borderline Rejection After Renal Transplantation.
    Kidney Int. 2022 Nov 24:S0085-2538(22)00969-3. doi: 10.1016/j.kint.2022.
    PubMed     Abstract available


  40. MEINDERTS JR, Schreuder MF, de Jong MFC
    Pregnancy after kidney transplantation: more attention is needed for long-term follow-up of the offspring.
    Kidney Int. 2022;102:1190-1191.
    PubMed    


  41. HAAS M, Mirocha J, Huang E, Najjar R, et al
    A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.
    Kidney Int. 2022 Nov 1. pii: S0085-2538(22)00912.
    PubMed     Abstract available


    October 2022
  42. GUHA C, van Zwieten A, Khalid R, Kim S, et al
    Longitudinal assessment of the health-related quality of life of children and adolescents with chronic kidney disease.
    Kidney Int. 2022 Oct 28. pii: S0085-2538(22)00906.
    PubMed     Abstract available


  43. MOREAU A, Kervella D, Bouchet-Delbos L, Braudeau C, et al
    A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
    Kidney Int. 2022 Oct 25. pii: S0085-2538(22)00845.
    PubMed     Abstract available


  44. JESUDASON S, Piccoli GB
    Pregnancy outcomes after kidney transplantation: the challenges of success.
    Kidney Int. 2022;102:697-699.
    PubMed     Abstract available


    September 2022
  45. ROSEN RJ, Prakash-Polet S, Liu P, Batal I, et al
    The Case | An unusual cause of proteinuria in a kidney transplant recipient.
    Kidney Int. 2022;102:673-674.
    PubMed    


  46. KIBERD BA, Lim WH
    The windows of opportunity.
    Kidney Int. 2022;102:479-481.
    PubMed     Abstract available


  47. GIARRATANO Y, Pugh D, Farrah TE, Oniscu GC, et al
    Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors.
    Kidney Int. 2022;102:661-665.
    PubMed    


    August 2022
  48. BENOTMANE I, Velay A, Vargas GG, Olagne J, et al
    A rapid decline in the anti-receptor binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.
    Kidney Int. 2022 Aug 13. pii: S0085-2538(22)00616.
    PubMed    


  49. CACHO J, Nicolas D, Bodro M, Cuadrado-Payan E, et al
    USE OF REMDESIVIR IN KIDNEY TRANSPLANT RECIPIENTS WITH SARS-COV-2 OMICRON INFECTION.
    Kidney Int. 2022 Aug 11. pii: S0085-2538(22)00613.
    PubMed    


  50. BOU SABA J, Cherukuri A
    Antigen-specific B cells in kidney transplantation.
    Kidney Int. 2022;102:233-235.
    PubMed     Abstract available


    July 2022
  51. KAMINSKI H, Gigan M, Vermorel A, Charrier M, et al
    Covid-19 morbidity decreases with Tixagevimab/cilgavimab preexposure prophylaxis in kidney transplant recipients non/low vaccine responders.
    Kidney Int. 2022 Jul 20. pii: S0085-2538(22)00550.
    PubMed    


  52. MANOHARAN K, Gupta P, Mehta H, Nada R, et al
    The Case | Inflammatory polyarthritis in a kidney transplant recipient.
    Kidney Int. 2022;102:215-216.
    PubMed    


  53. JAMHOUR-CHELH K, Melendo-Viu M, Dobarro D, Raposeiras-Roubin S, et al
    Acute heart failure in a kidney transplant patient.
    Kidney Int. 2022;102:211.
    PubMed    


  54. VAN LOON E, Lamarthee B, de Loor H, Van Craenenbroeck AH, et al
    Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology.
    Kidney Int. 2022;102:183-195.
    PubMed     Abstract available


    June 2022
  55. GOSSELINK ME, van Buren MC, Kooiman J, Groen H, et al
    A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes.
    Kidney Int. 2022 Jun 28. pii: S0085-2538(22)00468.
    PubMed     Abstract available


  56. SCHOLD JD, Huml AM, Poggio ED, Reese PP, et al
    A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States.
    Kidney Int. 2022 Jun 24. pii: S0085-2538(22)00462.
    PubMed     Abstract available


  57. ANDERSON B, Qasim M, Evison F, Gallier S, et al
    A population cohort analysis of English transplant centers indicates major adverse cardiovascular events after kidney transplantation.
    Kidney Int. 2022 Jun 15. pii: S0085-2538(22)00450.
    PubMed     Abstract available


  58. VAN DER WEIJDEN J, Mahesh SVK, van Londen M, Bakker SJL, et al
    Early increase in single-kidney glomerular filtration rate after living kidney donation predicts long-term kidney function.
    Kidney Int. 2022;101:1251-1259.
    PubMed     Abstract available


    May 2022
  59. SURI RS, Lee JY, Ban MR, Shrum B, et al
    Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans.
    Kidney Int. 2022 May 27. pii: S0085-2538(22)00381.
    PubMed    


  60. MONTAGUD-MARRAHI E, Cuadrado-Payan E, Hermida E, Cacho J, et al
    Preemptive simultaneous pancreas kidney transplantation has survival benefit to patient.
    Kidney Int. 2022 May 26. pii: S0085-2538(22)00385.
    PubMed     Abstract available


  61. BERTRAND D, Laurent C, Lemee V, Lebourg L, et al
    Efficacy of anti SARS-CoV-2 monoclonal antibodies prophylaxis and vaccination on Omicron COVID-19 in kidney transplant recipients.
    Kidney Int. 2022 May 23. pii: S0085-2538(22)00382.
    PubMed    


  62. BASU S, Dorling A
    Regulation of T- and B-cell interactions determines the clinical phenotype associated with donor-specific antibodies.
    Kidney Int. 2022;101:877-879.
    PubMed     Abstract available


    April 2022
  63. BURTON H, McLaughlin L, Shiu KY, Shaw O, et al
    The phenotype of HLA-binding B-cells from sensitized kidney transplant recipients correlates with clinically prognostic patterns of interferon-gamma production against purified HLA proteins.
    Kidney Int. 2022 Apr 25. pii: S0085-2538(22)00339.
    PubMed     Abstract available


  64. AL JURDI A, Gassen RB, Borges TJ, Lape IT, et al
    Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.
    Kidney Int. 2022 Apr 13. pii: S0085-2538(22)00288.
    PubMed    


  65. CHAVAROT N, Melenotte C, Amrouche L, Rouzaud C, et al
    Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection.
    Kidney Int. 2022 Apr 11. pii: S0085-2538(22)00272.
    PubMed    


  66. HUANG E, Jordan SC
    Donor-derived cell-free DNA in kidney transplantation: evolving concepts and potential limitations.
    Kidney Int. 2022;101:676-677.
    PubMed     Abstract available


  67. LASSEN E, Daehn IS
    Hypertrophy and glomerular cell adaptation through crosstalk leads to glomerular injury after kidney transplantation.
    Kidney Int. 2022;101:673-676.
    PubMed     Abstract available


  68. LOGEL SN, Connor EL, Paloian NJ
    The Case | A 17-year-old boy with growth failure and chronic kidney disease.
    Kidney Int. 2022;101:837-838.
    PubMed    


    March 2022
  69. PERKINS GB, Tunbridge M, Salehi T, Chai CS, et al
    Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19.
    Kidney Int. 2022 Mar 15. pii: S0085-2538(22)00172.
    PubMed    


  70. SUWELACK B, Berger K, Wolters H, Gerss JWO, et al
    Results of the prospective multicenter SoLKiD cohort study indicate bio-psycho-social outcome risks to kidney donors 12 months after donation.
    Kidney Int. 2022;101:597-606.
    PubMed     Abstract available


    February 2022
  71. BENOTMANE I, Bruel T, Planas D, Fafi-Kremer S, et al
    A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the delta variant in kidney transplant recipients.
    Kidney Int. 2022 Feb 26. pii: S0085-2538(22)00168.
    PubMed    


  72. MASSET C, Benotmane I, Dantal J, Garandeau C, et al
    A fourth SARS-Cov-2 mRNA vaccine in strictly seronegative kidney transplant recipients.
    Kidney Int. 2022 Feb 12. pii: S0085-2538(22)00093.
    PubMed    


  73. ERPICUM P, Grosch S, Bonvoisin C, Bouquegneau A, et al
    The Case | An unusual cause of renal vascular thrombi after kidney transplantation.
    Kidney Int. 2022;101:427-428.
    PubMed    


    January 2022
  74. LOUIS K, Fadakar P, Macedo C, Yamada M, et al
    Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation.
    Kidney Int. 2022 Jan 25. pii: S0085-2538(22)00027.
    PubMed     Abstract available


  75. DUCLOUX D, Courivaud C
    REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme.
    Kidney Int. 2022 Jan 4. pii: S0085-2538(21)01216.
    PubMed    


  76. JEFFERIS J, Kassianos AJ, Grivei A, Doucet B, et al
    SARS-CoV-2 vaccination-associated collapsing glomerulopathy in a kidney transplant recipient.
    Kidney Int. 2022 Jan 4. pii: S0085-2538(21)01219.
    PubMed    


  77. SALEM F, Perin L, Sedrakyan S, Angeletti A, et al
    The spatially resolved transcriptional profile of acute T cell-mediated rejection in a kidney allograft.
    Kidney Int. 2022;101:131-136.
    PubMed     Abstract available


    December 2021
  78. BENNING L, Morath C, Bartenschlager M, Reineke M, et al
    Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared to two-dose BNT162b2 vaccination in kidney transplant recipients.
    Kidney Int. 2021 Dec 23. pii: S0085-2538(21)01169.
    PubMed    


  79. SUGIANTO RI, Memaran N, Schmidt BMW, Doyon A, et al
    Insights from the 4C-T Study suggest increased cardiovascular burden in girls with end stage kidney disease before and after kidney transplantation.
    Kidney Int. 2021 Dec 21. pii: S0085-2538(21)01163.
    PubMed     Abstract available


  80. MENON R, Otto EA, Berthier CC, Nair V, et al
    Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants.
    Kidney Int. 2021 Dec 21. pii: S0085-2538(21)01162.
    PubMed     Abstract available


  81. LOUPY A, Mengel M, Haas M
    30 years of the International Banff Classification for Allograft Pathology: The Past, Present and Future of Kidney Transplant Diagnostics.
    Kidney Int. 2021 Dec 16. pii: S0085-2538(21)01142.
    PubMed     Abstract available


  82. CALLEMEYN J, Lamarthee B, Koenig A, Koshy P, et al
    Allorecognition and the spectrum of kidney transplant rejection.
    Kidney Int. 2021 Dec 13. pii: S0085-2538(21)01143.
    PubMed     Abstract available


  83. MASSET C, Ville S, Garandeau C, Le Borgne F, et al
    Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation.
    Kidney Int. 2021 Dec 8. pii: S0085-2538(21)01136.
    PubMed    


  84. HEYBELI C, Bentall A, Wen J, Alexander MP, et al
    Corrigendum to Heybeli C, Bentall A, Wen J, et al. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int. 2021;99:707-715.
    Kidney Int. 2021;100:1348-1349.
    PubMed    


    November 2021
  85. ASHCROFT J, Leighton P, Elliott TR, Hosgood SA, et al
    Extracellular Vesicles in Kidney Transplantation: A State of the Art Review.
    Kidney Int. 2021 Nov 25. pii: S0085-2538(21)01082.
    PubMed     Abstract available


    October 2021
  86. YI Z, Salem F, Menon MC, Keung K, et al
    Deep learning identified pathological abnormalities predictive of graft loss in kidney transplant biopsies.
    Kidney Int. 2021 Oct 29. pii: S0085-2538(21)01025.
    PubMed     Abstract available


  87. BERTRAND D, Hamzaoui M, Lemee V, Lamulle J, et al
    Antibody and T cell response to a third dose of SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients.
    Kidney Int. 2021 Oct 4. pii: S0085-2538(21)00924.
    PubMed    


  88. DUCLOUX D, Courivaud C
    Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?
    Kidney Int. 2021;100:939-940.
    PubMed    


  89. LEFAUCHEUR C, Louis K, Philippe A, Loupy A, et al
    The emerging field of non-human leukocyte antigen antibodies in transplant medicine and beyond.
    Kidney Int. 2021;100:787-798.
    PubMed     Abstract available


    September 2021
  90. PEDERSEN RM, Bang LL, Tornby DS, Kierkegaard H, et al
    The SARS-CoV-2-neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine.
    Kidney Int. 2021 Sep 20. pii: S0085-2538(21)00866.
    PubMed    


  91. WESTHOFF TH, Seibert FS, Anft M, Blazquez-Navarro A, et al
    A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral non-response.
    Kidney Int. 2021 Sep 9. pii: S0085-2538(21)00850.
    PubMed    


  92. AZZI Y, Raees H, Wang T, Cleare L, et al
    Risks factors associated with poor response to COVID-19 vaccination in kidney transplant recipients.
    Kidney Int. 2021 Sep 2. pii: S0085-2538(21)00826.
    PubMed    


    August 2021
  93. DE GREEF J, Devresse A, Albichr IS, Scohy A, et al
    Better Late than Never: Eventual Seroconversion against SARS-CoV-2 in a Kidney Transplant Recipient after Repeated Immune Challenge and Monoclonal Antibody Therapy.
    Kidney Int. 2021 Aug 31. pii: S0085-2538(21)00825.
    PubMed    


  94. MASSET C, Kerleau C, Garandeau C, Ville S, et al
    A third injection of BNT162b2 mRNA Covid-19 vaccine in kidney transplant recipients improves the humoral immune response.
    Kidney Int. 2021 Aug 30. pii: S0085-2538(21)00809.
    PubMed    


  95. CHAVAROT N, Parize P, Podglajen I, Sberro-Soussan R, et al
    The Case | Cardiac tamponade in a kidney transplant recipient with chronic inflammation.
    Kidney Int. 2021;100:487-488.
    PubMed    


  96. MENGEL M, Lubetzky M
    Do we need to treat chronic active T cell-mediated rejection?
    Kidney Int. 2021;100:275-277.
    PubMed     Abstract available


  97. CAILLARD S, Chavarot N, Bertrand D, Kamar N, et al
    Occurrence of severe COVID-19 in vaccinated transplant patients.
    Kidney Int. 2021;100:477-479.
    PubMed    


  98. ARYKBAEVA AS, de Vries DK, Doppenberg JB, Engelse MA, et al
    Metabolic needs of the kidney graft undergoing normothermic machine perfusion.
    Kidney Int. 2021;100:301-310.
    PubMed     Abstract available


  99. KUNG VL, Sandhu R, Haas M, Huang E, et al
    Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy.
    Kidney Int. 2021;100:391-400.
    PubMed     Abstract available


  100. SENEV A, Van Loon E, Lerut E, Callemeyn J, et al
    Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies.
    Kidney Int. 2021;100:401-414.
    PubMed     Abstract available


    July 2021
  101. TAMBUR AR, Kosmoliaptsis V, Claas FH, Mannon RB, et al
    Significance of HLA-DQ in kidney transplantation - Time to re-evaluate HLA matching priorities to improve transplant outcomes? An expert review and recommendations.
    Kidney Int. 2021 Jul 8. pii: S0085-2538(21)00657.
    PubMed     Abstract available


  102. DALOUL R, Pesavento T, Goldberg DS, Reese PP, et al
    A Review of kidney transplantation from HCV-Viremic Donors into Negative Recipients.
    Kidney Int. 2021 Jul 5. pii: S0085-2538(21)00669.
    PubMed     Abstract available


  103. MADHAVAN SM
    APOL1 genotyping in kidney transplantation: a look into the future.
    Kidney Int. 2021;100:32-34.
    PubMed    


  104. KUMAR V, Locke JE
    APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra).
    Kidney Int. 2021;100:30-32.
    PubMed    


  105. FREEDMAN BI, Poggio ED
    APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro).
    Kidney Int. 2021;100:27-30.
    PubMed    


  106. YAMADA M, Iwamoto H, Konno O, Kihara Y, et al
    Pelvic arteriovenous malformation in a kidney transplant recipient.
    Kidney Int. 2021;100:246.
    PubMed    


  107. BERCHTOLD L, Letouze E, Alexander MP, Canaud G, et al
    Corrigendum to Berchtold L, Letouze E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
    Kidney Int. 2021;100:243.
    PubMed    


    June 2021
  108. IKIZLER TA, Coates PT, Rovin BH, Ronco P, et al
    Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
    Kidney Int. 2021;99:1275-1279.
    PubMed     Abstract available


  109. RAMSPEK CL, El Moumni M, Wali E, Heemskerk MBA, et al
    Development and external validation study combining existing models and recent data into an up-to-date prediction model for evaluating kidneys from older deceased donors for transplantation.
    Kidney Int. 2021;99:1459-1469.
    PubMed     Abstract available


    May 2021
  110. DOLFF S, Baotong Z, Korth J, De L, et al
    Evidence of Cell Mediated Immune response in kidney transplants with negative mRNA-1273 Antibody Response.
    Kidney Int. 2021 May 21. pii: S0085-2538(21)00511.
    PubMed    


  111. THIRUNAVUKKARASU B, Nada R, Ramachandran R, Sakhuja V, et al
    Epstein-Barr virus-associated hepatic smooth muscle tumor post-renal transplant.
    Kidney Int. 2021;99:1245.
    PubMed    


  112. LIANG EN W, Tan CS, Conceicao EP, Venkatachalam I, et al
    Zero health care-associated respiratory viral infections: impact of enhanced infection prevention on a renal unit during the coronavirus disease 2019 pandemic.
    Kidney Int. 2021;99:1236-1238.
    PubMed    


  113. SOTOMAYOR CG, Groothof D, Vodegel JJ, Eisenga MF, et al
    Plasma cadmium is associated with increased risk of long-term kidney graft failure.
    Kidney Int. 2021;99:1213-1224.
    PubMed     Abstract available


  114. DUJARDIN A, Lorent M, Foucher Y, Legendre C, et al
    Time-dependent lymphocyte count after transplantation is associated with higher risk of graft failure and death.
    Kidney Int. 2021;99:1189-1201.
    PubMed     Abstract available


    April 2021
  115. CHANG CC, Vlad G, Vasilescu ER, Husain SA, et al
    Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19-recovered patients who received a kidney transplant.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00457.
    PubMed    


  116. PUTTARAJAPPA CM, Jorgensen D, Yabes JG, Jeong K, et al
    Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00460.
    PubMed     Abstract available


  117. DEL BELLO A, Marion O, Delas A, Congy-Jolivet N, et al
    Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney-transplant patient.
    Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00466.
    PubMed    


  118. CLAUDIO P, Rosaria CM
    The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation.
    Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00454.
    PubMed     Abstract available


  119. BENOTMANE I, Gautier-Vargas G, Cognard N, Olagne J, et al
    Low immunization rates among kidney transplant recipients who received two doses of the mRNA-1273 SARS-CoV-2 vaccine.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00389.
    PubMed    


  120. COOREY CP, Sharma A, Muller S, Yang JYH, et al
    Prediction modeling-part 2: using machine learning strategies to improve transplantation outcomes.
    Kidney Int. 2021;99:817-823.
    PubMed     Abstract available


    November 2020
  121. TURNER MP, Storey BC, Mittal S, Macanovic J, et al
    Candida crescents in a renal allograft.
    Kidney Int. 2020;98:1356.
    PubMed    


    May 2020
  122. ZHANG Z, Menon MC, Zhang W, Stahl E, et al
    Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis.
    Kidney Int. 2020 May 23. pii: S0085-2538(20)30540.
    PubMed     Abstract available


    January 2020
  123. SIGOGNE M, Culty T, Meria P, Demiselle J, et al
    Encrusted pyelitis in a kidney allograft.
    Kidney Int. 2020;97:217.
    PubMed    


  124. PERAZELLA MA, Shirali AC
    Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?
    Kidney Int. 2020;97:62-74.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.